European Healthcare Stocks Surge After US-Pfizer Deal on Drug Pricing

European Healthcare Stocks Advance

• 📈 European healthcare stocks experienced a significant jump on Wednesday, following positive movements in the United States.
• 💡 This surge is attributed to a recent agreement between US-based drug maker Pfizer and President Donald Trump concerning prescription drug prices.

Impact of US-Pfizer Deal

• 🤝 The agreement, which involves lowering drug prices in the Medicaid program in exchange for tariff relief, has reduced uncertainty for the healthcare sector.
• ⚠️ Healthcare stocks in both the US and Europe had been underperforming due to concerns over the Trump administration's stance on drug pricing.
• 🎯 Pfizer is the first major drug company to announce such a deal after President Trump sent letters in July urging companies to lower prices to match overseas rates.

Market Performance and Key Companies

• 📊 Europe's healthcare sector index rose by 2.77%, potentially marking its largest daily percentage gain since April if sustained.
• 🚀 Companies like AstraZeneca, Ambu, Merck, and Storius were among those that saw their stock prices climb.
• 💰 Pfizer shares had previously risen 7% on Tuesday, with other US pharmaceutical stocks also showing gains.